Aveanna Healthcare Holdings, Inc. Stock Price, News & Analysis

Aveanna (NASDAQ: AVAH) announced that management will participate virtually in the BofA Securities Home Care Conference on December 9, 2025.

Management will present at 12:30 PM ET, hold one-on-one investor meetings the same day, and offer a simultaneous webcast available via the company Investor Relations website with an online replay posted for a limited time.

Aveanna Healthcare (NASDAQ: AVAH) reported Q3 2025 revenue $621.9M (+22.2% YoY) and net income $14.1M versus a prior-year net loss. Q3 Adjusted EBITDA $80.1M (12.9% margin, +67.5% YoY). Nine-month revenue was $1.7707B (+17.7%) with Adjusted EBITDA $235.9M (+83.7%).

The company raised full-year 2025 guidance to revenue >$2.375B and Adjusted EBITDA >$300M. Liquidity: cash of $145.9M, securitization capacity $105.8M, undrawn revolver capacity ~$227M (≈$23M letters of credit). Total indebtedness was $1,490.0M; 2025 Term Loans bear interest at Term SOFR +3.75%. Free cash flow for nine months was $86.2M.

Aveanna Healthcare (NASDAQ: AVAH) announced the pricing of a secondary offering by selling stockholders affiliated with J.H. Whitney Equity Partners VII: 10,000,000 shares priced at $9.00 per share, with underwriters granted a 30-day option to buy up to an additional 1,500,000 shares.

The company will not sell shares or receive proceeds from the Offering. The sale is expected to settle on October 23, 2025, subject to customary closing conditions. A Form S-3 shelf registration (declared effective) and prospectus supplement are available through the SEC EDGAR system.

Aveanna Healthcare (NASDAQ: AVAH) announced on October 21, 2025 that certain selling stockholders affiliated with J.H. Whitney Equity Partners VII have commenced a secondary offering of 10,000,000 shares of common stock, with underwriters granted a 30-day option to purchase up to an additional 1,500,000 shares.

The selling stockholders will receive all net proceeds; the company is not offering shares and will not receive any proceeds from the sale. Jefferies and J.P. Morgan are joint lead book-running managers; Barclays and RBC are bookrunners. A Form S-3 shelf registration (including a prospectus) has been filed and declared effective by the SEC.

Aveanna Healthcare (NASDAQ: AVAH) reported preliminary results for the three-month period ended September 27, 2025. Management expects revenue of $616M–$624M, up ~21.0%–22.6% year-over-year; net income of $11M–$15M, up ~125.7%–135.0% year-over-year; and Adjusted EBITDA of $77M–$81M, up ~61.0%–69.3% year-over-year.

Results are preliminary and unaudited, subject to closing procedures and potential material adjustments. The company disclosed significant non-GAAP adjustments, including $15.7M–$16.9M of fees related to debt modifications and various acquisition and integration costs.

Aveanna (NASDAQ: AVAH) will release its third quarter 2025 results before the market open on Thursday, November 6, 2025, followed by a conference call at 10:00 a.m. ET the same day.

Investors can join the live call by dialing 1-877-407-0789 (U.S.) or 1-201-689-8562 (international). A replay will be available three hours after the call by dialing 1-844-512-2921 (U.S.) or 1-412-317-6671 (international) using passcode 13755427. The telephone replay is available until November 13, 2025, and a simultaneous webcast and online replay will be hosted on the company Investor Relations website at https://ir.aveanna.com/.

Aveanna Healthcare Holdings (NASDAQ: AVAH) announced its management team will participate in the Deutsche Bank Annual Leveraged Finance Conference in Austin, TX on October 15, 2025. During the conference, the management will be available for one-on-one meetings with investors.

Aveanna Healthcare (Nasdaq: AVAH) has successfully completed a significant debt refinancing transaction. The company has refinanced its $886.0 million first lien term loans and secured $439.0 million in incremental first lien term loans, bringing the total to $1.325 billion with extended maturity to 2032.

Additionally, AVAH increased its revolving credit facility from $170.3 million to $250.0 million, extending its maturity to 2030. The company used the proceeds to fully repay its $415.0 million second lien term loans. Barclays Bank PLC and Jeffries Finance LLC acted as co-lead arrangers for the transaction.

Aveanna Healthcare Holdings (NASDAQ: AVAH) announced its participation in the upcoming Jefferies Healthcare Services Conference in Nashville on September 30, 2025. The company's management team will engage in one-on-one investor meetings and conduct a fireside chat at 3:00 PM Central Time.

Investors can access the fireside chat through a live webcast on Aveanna's Investor Relations website at ir.aveanna.com. A replay will be available for a limited time after the event.